Financials
Financial year 2025
Gross margin
€ 279,789
▼ 4% vs 2024
Profit
Growing€ 142,331
▲ 5% vs 2024
Debts
Low€ 564,793
▼ 10% vs 2024
DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie from Zele, company number BE0899915916, closed financial year 2025 with a result of € 142,331 after tax. For that financial year DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie recorded a gross margin of € 279,789 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 135,573 to € 142,331. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 5, 2026.
What happened at DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie?
What happened at DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 142,331 (▲ 5% vs 2024). filed late Source: NBB ↗
- Saskia ROBBRECHT became a director. NBB
- New establishment in Zele. KBO
- Start of the company according to the CBE. KBO
In short
From € 120,175 profit in 2022 to € 142,331 profit in 2025.
Paid € 229,103 in corporate taxes since 2022.
Best year ever: 2023, with € 148,123 profit.
Paid out € 28,397 in dividends to the owners in total.
A new publication or filing at DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie? We notify you, reason included.
Follow DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologieNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie is Saskia ROBBRECHT.
Directors
According to the 2025 annual accounts
Saskia ROBBRECHT
Bestuurder
since 2024
Establishments
Establishment units
Physical locations of this company
Scheldestraat 113
9240 Zele
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0899.915.916
- VAT number
- BE 0899.915.916
- Registered office
- Scheldestraat 113, 9240 Zele
- Names & denominations
- DR.SASKIA ROBBRECHT, inwendige geneeskunde-endocrinologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 August 2008
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van medisch specialisten
Overige persoonlijke diensten
Andere vormen van maatschappelijke dienstverlening zonder huisvesting, neg